Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome (NCT06244433) | Clinical Trial Compass
RecruitingNot Applicable
Identification of Genetic Variants Associated With Unexpected Infant Death Syndrome
France650 participantsStarted 2024-08-27
Plain-language summary
This is a multicenter genetic study aimed at identifying new genes/variants associated with sudden infant death syndrome (SIDS) based on whole-genome sequencing of family trios
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Child Inclusion Criteria
* Death of a child between 0 and 2 years of age due to sudden unexpected death in infant
* Child included in the French SUDI registry with effective participation in the biocollection
* Children who also meet the inclusion criteria for the BIOMINRISK-NEUROBIO (axis 2) and BIOMINRISK-RADIO-ANAT (axis 3) studies in the overall BIOMINRISK project.
Parents Inclusion Criteria
* Biological parents of the child included in the BIOMINRISK study
* Parents who have both signed the consent form for blood collection and inclusion of their samples in the biocollection
* parents beneficiaries of a social security or similar scheme
Child Exclusion Criteria:
* Presence of a known metabolic, genetic or syndromic pathology at the time of death
Parents Exclusion Crtiteria:
* Parent under guardianship
* Presence of a known metabolic, genetic or syndromic pathology